AHRQ on percutaneous heart valves
This article was originally published in The Gray Sheet
Executive Summary
Agency for Healthcare Research and Quality is accepting public submissions of scientific data on percutaneous heart valves through Aug. 20. AHRQ is reviewing the technology as part of a new effort to release rapid reports on emerging clinical interventions. The 1technical brief will include a description of clinical studies completed and underway for percutaneous aortic, mitral and pulmonic valves, as well as information on transcatheter implant techniques
You may also be interested in...
AHRQ Maps Out Data Needs For Percutaneous Heart Valves
The Agency for Healthcare Research and Quality is calling for the development of decision models, systematic data reviews and long-term registries in addition to randomized trials, to understand the risks and benefits of percutaneous heart valve replacements
Small Sterilization Companies Poised To Meet EtO Emissions Goals On Time
Small sterilizers told Medtech Insight that they were ready for the EPA’s controversial EtO emissions rule, while community advocates expressed concerns.
Day One Springs Into Commercial Action With Ojemda Approval
The company is targeting around 200 centers that treat the vast majority of the few thousand pediatric low-grade glioma patients who are candidates for the RAF-targeting drug.